Carregant...
TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
Cisplatin is a common chemotherapeutic agent against ovarian cancer; however, drug resistance is a major limiting factor for its use in clinical treatment. The underlying mechanisms of cisplatin resistance in ovarian cancer have not yet been fully elucidated. Thus, this study aimed to elucidate some...
Guardat en:
| Publicat a: | Oncol Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718101/ https://ncbi.nlm.nih.gov/pubmed/31524236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7258 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|